Risk assessment in haematopoietic stem cell transplantation: Stem cell source
- 30 June 2007
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Haematology
- Vol. 20 (2), 265-280
- https://doi.org/10.1016/j.beha.2006.09.006
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003Bone Marrow Transplantation, 2005
- Hematopoetic stem cell transplantation for solid tumors in EuropeAnnals of Oncology, 2004
- Hematopoietic stem cell transplantation for hematological malignancies in EuropeLeukemia, 2003
- Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity surveyBone Marrow Transplantation, 2002
- Current trends in hematopoietic stem cell transplantation in EuropeBlood, 2002
- Economics, health care systems and utilization of haematopoietic stem cell transplants in EuropeBritish Journal of Haematology, 2002
- Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?Bone Marrow Transplantation, 2001
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapyBlood, 1993
- The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis [see comments]Blood, 1993
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992